When measurable changes in the brain such as abnormal levels of beta-amyloid, changes in tau protein, and other changes related to the occurrence of AD occur, the brain compensates to allow individuals to continue functioning normally (Alzheimer’s Association, 2022). This evidence concerns the gene MAPT and Alzheimer disease.